ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$114M |
| 2 |
XYZ
Block Inc
XYZ
|
+$78M |
| 3 |
Teladoc Health
TDOC
|
+$34.8M |
| 4 |
Zillow
Z
|
+$29.6M |
| 5 |
Teradyne
TER
|
+$29.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$107M |
| 2 |
JD.com
JD
|
+$73.4M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$68.7M |
| 4 |
Pacific Biosciences
PACB
|
+$49.3M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.11% |
| 2 | Healthcare | 25.71% |
| 3 | Communication Services | 15.8% |
| 4 | Consumer Discretionary | 9.58% |
| 5 | Industrials | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Iovance Biotherapeutics
IOVA
$2.78B
| $6.43M | 0.26% |
726,360
+301,540
| +71% | +$2.91M |
|
52
Mercado Libre
MELI
$92B
| $6.37M | 0.26% |
21,765
-100,582
| -82% | -$32.6M |
|
53
Aptiv
APTV
$10.1B
| $5.75M | 0.23% |
93,442
-519,343
| -85% | -$37.6M |
|
|
LOXO
54
DELISTED
Loxo Oncology, Inc
LOXO
| $5.66M | 0.23% |
+40,440
| New | +$6.14M |
|
55
Trimble
TRMB
$13.8B
| $5.65M | 0.23% |
171,609
-11,808
| -6% | -$434K |
|
|
ZUO
56
DELISTED
Zuora, Inc.
ZUO
| $5.62M | 0.23% |
309,589
+10,320
| +3% | +$198K |
|
57
Atlassian
TEAM
$36.6B
| $5.36M | 0.22% |
+60,252
| New | +$4.77M |
|
58
Regeneron Pharmaceuticals
REGN
$80B
| $5.2M | 0.21% |
13,921
-9,319
| -40% | -$3.41M |
|
|
RUBY
59
DELISTED
Rubius Therapeutics, Inc
RUBY
| $5.07M | 0.21% |
315,152
+126,884
| +67% | +$2.31M |
|
60
Pinduoduo
PDD
$131B
| $4.93M | 0.2% |
+219,730
| New | +$4.63M |
|
61
Autodesk
ADSK
$52.9B
| $4.73M | 0.19% |
36,761
-641
| -2% | -$86.6K |
|
|
EB
62
DELISTED
Eventbrite
EB
| $4.24M | 0.17% |
+152,573
| New | +$4.52M |
|
63
Incyte
INCY
$24.4B
| $4.21M | 0.17% |
66,147
+2,504
| +4% | +$163K |
|
64
Twilio
TWLO
$37.5B
| $4.04M | 0.16% |
+45,237
| New | +$3.67M |
|
65
Align Technology
ALGN
$12.1B
| $3.96M | 0.16% |
18,914
+6,932
| +58% | +$1.75M |
|
66
Arcturus Therapeutics
ARCT
$195M
| $3.69M | 0.15% |
815,176
+41,404
| +5% | +$255K |
|
67
Codexis
CDXS
$159M
| $3.58M | 0.15% |
+214,298
| New | +$3.7M |
|
68
Alphabet (Google) Class C
GOOG
$4.33T
| $3.1M | 0.13% |
59,860
-250,020
| -81% | -$13.4M |
|
|
BLCM
69
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $3.02M | 0.12% |
103,349
+44,328
| +75% | +$1.97M |
|
|
ANSS
70
DELISTED
Ansys
ANSS
| $3.01M | 0.12% |
21,053
-444
| -2% | -$69K |
|
71
Pluri
PLUR
$19.6M
| $2.67M | 0.11% |
42,339
+6,186
| +17% | +$531K |
|
72
Cognex
CGNX
$11.5B
| $2.67M | 0.11% |
68,945
+8,649
| +14% | +$375K |
|
73
Intuitive Surgical
ISRG
$134B
| $2.36M | 0.1% |
14,778
+3,951
| +36% | +$670K |
|
74
Elbit Systems
ESLT
$39.8B
| $2.27M | 0.09% |
19,952
-340
| -2% | -$41.2K |
|
75
HP
HPQ
$26.3B
| $2M | 0.08% |
97,957
-22,120
| -18% | -$516K |
|
Similar funds
ARK Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, ARK Investment Management held 214 positions worth $2.46B, down 26% from $3.31B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
ARK Investment Management withdrew a net $137M in Q4 2018, closing 20 positions and reducing 94 holdings. Its most notable exit was Biogen, an estimated $7.95M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 24% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, ARK Investment Management opened a new position in Loxo Oncology, Inc worth $5.66M.
- ARK Investment Management's largest Q4 2018 buy was Loxo Oncology, Inc: 40,440 shares worth $5.66M.
- ARK Investment Management added most to NVIDIA in Q4 2018, an estimated $114M increase.
- ARK Investment Management's biggest Q4 2018 reduction was Tesla, cutting an estimated $107M.
- ARK Investment Management fully exited Biogen in Q4 2018, selling an estimated $7.95M.
- ARK Investment Management's ten largest holdings make up 45% of its $2.46B portfolio in Q4 2018.
- ARK Investment Management opened 12 new positions and closed 20 in Q4 2018.
- ARK Investment Management's portfolio value fell 26% quarter-over-quarter to $2.46B.
Based on ARK Investment Management's 13F filing for Q4 2018, filed 1 Feb 2019.